Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >CDK/HDAC-IN-3
CDK/HDAC-IN-3
  • CDK/HDAC-IN-3

CDK/HDAC-IN-3 NEW

Price $1970 $2580 $3400
Package 25mg 50mg 100mg
Min. Order:
Supply Ability: 10g
Update Time: 2025-04-27

Product Details

Product Name: CDK/HDAC-IN-3 CAS No.: 2944087-54-9
Supply Ability: 10g Release date: 2025/04/27

Product Introduction

Bioactivity

NameCDK/HDAC-IN-3
DescriptionCDK/HDAC-IN-3 is an orally active dual inhibitor of HDACs and CDKs, offering potent and selective inhibition of CDK9, CDK12, CDK13, HDAC1, HDAC2, and HDAC3, with IC50 values of 98.32 nM, 98.85 nM, 100 nM, 62.12 nM, 93.28 nM, and 82.87 nM, respectively, and is applicable in the treatment of acute myeloid leukemia (AML) [1].
In vitroCDK/HDAC-IN-3 (compound 33a) at 1 μM demonstrates potent and selective inhibition of CDK9, CDK12, CDK13, HDAC1, HDAC2, and HDAC3 with IC50 values of 98.32 nM, 98.85 nM, 100 nM, 62.12 nM, 93.28 nM, and 82.87 nM, respectively [1]. At 0.5 μM and 1.0 μM, this compound significantly induces the differentiation of leukemia stem cell-like cells and inhibits AML proliferation [1]. Additionally, at 0.5 μM, 1.0 μM, and 2.0 μM, CDK/HDAC-IN-3 markedly promotes the differentiation of LSCs [1]. The compound also exhibits inhibitory effects on U937, HL-60, SKNO-1, and Kasumi-1 cells with IC50 values of 0.72 μM, 1.43 μM, 1.63 μM, and 0.89 μM, respectively [1].
In vivoCDK/HDAC-IN-3 (compound 33a) demonstrates good oral bioavailability when administered intravenously (i.v.) at 5 mg/kg and orally (p.o.) at 25 mg/kg [1].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Inhibitors RelatedPanobinostat | Theophylline monohydrate | Valproic acid sodium salt | Sodium 4-phenylbutyrate | Acefylline | Vorinostat | Valproic Acid | Curcumin | Parthenolide | 4-Phenylbutyric acid | Theophylline | Methyl L-histidinate dihydrochloride

Company Profile Introduction

TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds. 170+ Compound Libraries, 10000+ Noval Small Molecucles,16000+ Nature Compounds TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$34.00/1mg
VIP3Y
TargetMol Chemicals Inc.
2025-04-29
$40.00/1mg
VIP5Y
TargetMol Chemicals Inc.
2025-05-19
$0.00/1g
VIP1Y
Wuhan Circle Star Chem-medical Technology Co.,Ltd
2025-01-17
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, Massachusetts, USA
INQUIRY